fda stopping compounded semaglutide Drug compounders sue over declaration ending Wegovy shortage Last week @fda sends out
Description
Understanding how to maintain weight loss after tirzepatide is critical for long-term planning
Some small studies using gastric ultrasound and upper endoscopy have documented retained food particles in the stomachs of certain patients taking GLP-1 agonists after overnight fasting periods

Here's what's happening at the cellular level: Immune System Modulation : GLP-1 receptors are expressed on circulating T and B lymphocytes, human invariant natural killer T cells, and immature lymphocyte subsets, highlighting their role in lymphocyte maturation and regulatory T-cell functioning

Treatment is a long-term programme and there is no clinical benefit to rushing the titration process at the expense of tolerability

Nonetheless, given the heterogeneity of available data and the presence of residual uncertainty, a cautious and individualized clinical approach remains warranted

The rate of weight loss was the highest in these two weeks
